Results 271 to 280 of about 390,088 (309)

TREAT-AND-EXTEND REGIMEN USING RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Retina, 2017
To investigate the efficacy of a treat-and-extend regimen (TER) using ranibizumab to treat polypoidal choroidal vasculopathy (PCV).We retrospectively reviewed the medical records of 29 patients with PCV, who had been treated with a TER for 1 year. The primary outcome was the proportion of eyes that did not lose ≥3 best-corrected visual acuity (BCVA ...
Kang Yeun, Pak, Sung Who, Park, Ik Soo, Byon, Ji Eun, Lee   +3 more
openaire   +2 more sources

Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology, 2017
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve polypoidal choroidal vasculopathy (PCV).In a retrospective interventional case series of 58 eyes of 58 patients with PCV, we assessed best-corrected visual acuity (BCVA), central macular thickness (CMT), central choroidal thickness (CCT), and number of ...
Dan, Călugăru, Mihai, Călugăru
openaire   +4 more sources

Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a "Treat-and-Extend" Regimen.

Ophthalmology Retina, 2019
PURPOSE To report outcomes in patients with neovascular age-related macular degeneration (nAMD) after treatment with aflibercept for up to 4 years using a treat-and-extend (T&E) regimen. DESIGN Observational study.
Peter G. Traine, I. Pfister, S. Zandi, Jan Spindler, J. Garweg   +4 more
semanticscholar   +1 more source

Treat and extend protocol outcomes in diabetic macular edema: A narrative review

American Journal of Ophthalmic Clinical Trials, 2022
The objective of this study was to pool available data on change in visual acuity, number of injections, and change in central subfield thickness as reported by treat and extend (T&E) regimens for diabetic macular edema (DME) compared to monthly and pro re nata (PRN) regimens.
Param Bhatter, Abhinav Bheemidi, Justin C. Muste, Shirley Z. Wu, Molly J. E. Snider, Carolina C. S. Valentim, Rishi P. Singh   +6 more
openaire   +1 more source

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.

American journal of ophthalmology-glaucoma, 2019
PURPOSE To prospectively evaluate a treat and extend algorithm of ranibizumab with and without navigated laser to monthly dosing for center-involving diabetic macular edema. DESIGN This was a multicenter, randomized, clinical trial.
John F. Payne, C. Wykoff, W. Clark, Beau B. Bruce, David S. Boyer, David M. Brown, J. A. Wells, David L. Johnson, Matthew S. Benz, E. Chen, Richard H. Fish, Rosa Y. Kim, J. Major, Ronan E. O'Malley, A. Schefler, Ankoor R. Shah, T. P. Wong, Roger L. Novack, T. Chu, Firas M. Rahhal, Homayoun Tabandeh, R. Roe, Pouya Dayani, D. Liao, Alexander C. Walsh, Daniel D. Esmaili   +25 more
semanticscholar   +1 more source

Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper

Journal of Addiction Medicine
Abstract This case report highlights a 36-year-old male without history of psychiatric disease, chronic pain, or substance use disorder who developed severe substance use disorder per Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria to kratom.
Benjamin B, Swart, Charles, Reznikoff, Katie, Steen   +2 more
openaire   +2 more sources

The Treat-and-Extend Injection Regimen Versus Alternate Dosing Strategies in Age-related Macular Degeneration: A Systematic Review and Meta-analysis.

American journal of ophthalmology-glaucoma, 2018
PURPOSE To assess outcomes of the treat-and-extend (T&E) injection regimen for neovascular age-related macular degeneration (AMD) as compared to either a monthly or a pro re nata (PRN) treatment strategy.
Mali Okada, R. Kandasamy, E. Chong, Myra B McGuiness, R. Guymer   +4 more
semanticscholar   +1 more source

A benign hepatocellular adenoma treated by extended right lobectomy.

Annales chirurgiae et gynaecologiae. Supplementum, 1976
A 19-YEAR-OLD WOMAN WITH A LARGE BENIGN HEPATOCELLULAR ADENOMA IS PRESENTED. The initial symptom was continuous anaemia demanding transfusions twice a month. Coeliac angiography revealed the hepatic tumour, which was thought to be malignant. Angiography produced permanent paraplegia as a complication.
A, Sivula, M, Lempinen
openaire   +2 more sources

Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone

Pharmacology Biochemistry and Behavior, 2008
A monthly extended-release formulation of the opioid antagonist naltrexone (XR-NTX) is approved for treatment of alcohol dependence. There is little research regarding overriding chronic (>21 days) competitive opioid receptor blockade with opioids for acute pain.
Reginald L, Dean, Mark S, Todtenkopf, Daniel R, Deaver, Mahin F, Arastu, Nan, Dong, Krystal, Reitano, Kevin, O'Driscoll, Kristina, Kriksciukaite, David R, Gastfriend   +8 more
openaire   +2 more sources

INJECTION FREQUENCY OF AFLIBERCEPT VERSUS RANIBIZUMAB IN A TREAT-AND-EXTEND REGIMEN FOR CENTRAL RETINAL VEIN OCCLUSION: A Randomized Clinical Trial.

Retina, 2019
PURPOSE To prospectively investigate the injection frequency of aflibercept and ranibizumab in the treatment of macular edema in central retinal vein occlusion. METHODS Patients with treatment-naive central retinal vein occlusion and macular edema were
Manuel Casselholm de Salles, Urban Amrén, A. Kvanta, David Epstein   +3 more
semanticscholar   +1 more source